How to measure immune cell killing of tumor cells effectively
16 Mar 2021
Immuno-oncology (IO) has transformed cancer treatment and the number of treatments in the IO pipeline continues to grow. Whether the treatment is CAR-T cells, checkpoint inhibitors or adoptive T cell therapy, the mechanism of action includes T cell lysis of tumor cells.
Incucyte® Live-Cell Analysis offers walkaway monitoring of tumor cell lysis using fluorescent labels of cytotoxicity. In this webinar, we will present data using tumor antigen specific T cells from Cellero and widely available tumor cell lines, to demonstrate specific lysis of tumor cells. Important technical factors will be discussed.
Who should attend?
- Scientists and researchers in biotechnology, pharmaceuticals, biopharma and academia.